Screener
Organogenesis Holdings Inc. ORGO EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s EPS (diluted)?
- Organogenesis Holdings Inc. (ORGO) reported EPS (diluted) of -$0.77 in Q2 2026.
- How has Organogenesis Holdings Inc.'s EPS (diluted) changed year-over-year?
- Organogenesis Holdings Inc.'s EPS (diluted) decreased by 670.0% year-over-year, from -$0.10 to -$0.77.
- What is the long-term trend for Organogenesis Holdings Inc.'s EPS (diluted)?
- Over 3 years (2021 to 2025), Organogenesis Holdings Inc.'s EPS (diluted) has grown at a -45.8% compound annual growth rate (CAGR), from $0.69 to $0.11.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Organogenesis Holdings Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude